Indegene launches NEXT medical writing automation platform with GenAI
Indegene has launched NEXT Medical Writing Automation, a platform that uses generative AI to enhance medical writing. This tool integrates with existing systems to produce compliant documents efficie...ntly, allowing medical writers to focus on strategic tasks. It aims to streamline operations in clinical development and regulatory submissions by leveraging Indegene's AI engine, Cortex.
Indegene announces strategic partnership with Datavant
Indegene and Datavant have formed a strategic partnership to enhance patient recruitment for clinical trials, focusing on rare diseases. By integrating Datavant's data enrichment capabilities with In...degene's NEXT Patient Recruitment platform, the collaboration aims to streamline trial enrollment, reduce screen failures, and improve recruitment efficiency for biopharmaceutical companies.
Indegene has acquired BioPharm, a specialized marketing services agency based in Pennsylvania, to enhance its commercialization portfolio with AdTech capabilities. This acquisition, executed through ...Indegene's subsidiary ILSL Inc., aims to integrate AI and digital advertising to offer precise, scalable solutions for pharma companies. BioPharm's expertise in omnichannel strategy and data-driven campaign execution strengthens Indegene's leadership in the data-driven omnichannel and media space.
